Dietary fat differentially influences the lipids storage on the adipose tissue in metabolic syndrome patients

European Journal of Nutrition

Volumn 53, Issue 2, 2014, Pages 617-626

  Camargo, Antonio ^a,b   Meneses, Maria E ^a,b   Perez Martinez, Pablo ^a,b   Delgado Lista, Javier ^a,b   Jimenez Gomez, Yolanda ^b,c   Cruz Teno, Cristina ^a,b   Tinahones, Francisco J ^b,d   Paniagua, Juan A ^a,b   Perez Jimenez, Francisco ^a,b   Roche, Helen M ^e   Malagon, Maria M ^b,c   Lopez Miranda, Jose ^a,b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adipokines; Adipose tissue; Diet; Lipid metabolism; Metabolic syndrome

Indexed keywords

ACYL COENZYME A OXIDASE; ACYL COENZYME A OXIDASE 1; ADIPOCYTOKINE; ADIPONECTIN; CARBOXYLESTERASE; CARBOXYLESTERASE 1; CAVEOLIN; FATTY ACID BINDING PROTEIN 4; LEPTIN; LIPOPROTEIN LIPASE; MESSENGER RNA; MONOUNSATURATED FATTY ACID; PERILIPIN; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; RETINOL BINDING PROTEIN 4; SATURATED FATTY ACID; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; VIMENTIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CARBOHYDRATE DIET; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LIPID DIET; LIPID STORAGE; LOW FAT DIET; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; RNA ISOLATION; SUBCUTANEOUS FAT;

ADIPOKINES; ADIPOSE TISSUE; CARBOXYLIC ESTER HYDROLASES; CARRIER PROTEINS; DIET; DIETARY FATS; FASTING; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, OMEGA-3; FEMALE; GENE EXPRESSION; HUMANS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHOSPHOPROTEINS; PLACEBOS; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84896734270     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0570-2     Document Type: Article

References (40)

1. Morrison RF, Farmer SR (2000) Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr 130:3116S-3121S
2. Kim S, Moustaid-Moussa N (2000) Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr 130:3110S-3115S
3. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE (1996) Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553-2561
4. Matsuzawa Y (2006) The metabolic syndrome and adipocytokines. FEBS Lett 580:2917-2921
5. Phillips C, Lopez-Miranda J, Perez-Jimenez F, McManus R, Roche HM (2006) Genetic and nutrient determinants of the metabolic syndrome. Curr Opin Cardiol 21:185-193
6. Matsuzawa Y (2005) White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 19:637-647
7. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J (2006) Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49:394-397
8. Hung SC, Bartley G, Young SA, Albers DR, Dielman DR, Anderson WH, Yokoyama W (2009) Dietary fiber improves lipid homeostasis and modulates adipocytokines in hamsters. J Diabetes 1:194-206
9. Paniagua JA, Gallego de la Sacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F (2007) Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 30:1717-1723
10. Gnacinska M, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, Sworczak K (2009) Role of adipokines in complications related to obesity: a review. Adv Med Sci 54:150-157
11. Kawano J, Arora R (2009) The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 4:44-49
12. Shaw DI, Tierney AC, McCarthy S, Upritchard J, Vermunt S, Gulseth HL, Drevon CA, Blaak EE, Saris WH, Karlstrom B, Helal O, Defoort C, Gallego R, Lopez-Miranda J, Siedlecka D, Malczewska-Malec M, Roche HM, Lovegrove JA (2009) LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr 101:750-759
13. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24:e13-e18
14. Bickel PE, Tansey JT, Welte MA (2009) PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores. Biochim Biophys Acta 1791:419-440
15. Brasaemle DL, Dolios G, Shapiro L, Wang R (2004) Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem 279:46835-46842
16. Schaefer U, Schmeier S, Bajic VB (2011) TcoF-DB: dragon database for human transcription co-factors and transcription factor interacting proteins. Nucleic acids Res 39:D106-D110
17. Lavoie M, Ge D, Abou Elela S (2012) Regulation of conditional gene expression by coupled transcription repression and RNA degradation. Nucleic acids Res 40:871-883
18. Davis KE, Moldes M, Farmer SR (2004) The forkhead transcription factor FoxC2 inhibits white adipocyte differentiation. J Biol Chem 279:42453-42461
19. Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, Tanne D, Matas Z, Hibuse T, Fujita K, Nishizawa H, Adler Y, Motro M, Kihara S, Shimomura I, Behar S, Funahashi T (2007) Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler Thromb Vasc Biol 27:635-641
20. Bluher M, Williams CJ, Kloting N, Hsi A, Ruschke K, Oberbach A, Fasshauer M, Berndt J, Schon MR, Wolk A, Stumvoll M, Mantzoros CS (2007) Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 30:3110-3115
21. Ray H, Pinteur C, Frering V, Beylot M, Large V (2009) Depot-specific differences in perilipin and hormone-sensitive lipase expression in lean and obese. Lipids Health Dis 8:58
22. Virtue S, Vidal-Puig A (2010) Adipose tissue expandability, lipotoxicity and the metabolic syndrome - an allostatic perspective. Biochim Biophys Acta 1801:338-349
23. Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G (1996) Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19:1207-1213
24. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gustafsson IB, Storlien LH (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 44:312-319
25. Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447:959-965
26. Suhre K, Romisch-Margl W, de Angelis MH, Adamski J, Luippold G, Augustin R (2011) Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J Biomol Screen 16:467-475
27. Makowski L, Hotamisligil GS (2004) Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 134:2464S-2468S
28. Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP (2004) Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 53:1261-1270
29. Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart AC, Aber VR, Maseri A, Kluft C (1988) Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 62:635-637
30. Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR (1988) Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb Haemost 60:372-376
31. Segarra A, Chacon P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolome J, Camps J, Moliner E, Pelegri A, Marco F, Olmos A, Piera L (2001) Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 12:1255-1263
32. Khoury DE, Hwalla N, Frochot V, Lacorte JM, Chabert M, Kalopissis AD (2010) Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein. Atherosclerosis 210:307-313
33. Meneses ME, Camargo A, Perez-Martinez P, Delgado-Lista J, Cruz-Teno C, Jimenez-Gomez Y, Paniagua JA, Gutierrez-Mariscal FM, Tinahones FJ, Vidal-Puig A, Roche HM, Perez-Jimenez F, Malagon MM, Lopez-Miranda J (2011) Postprandial inflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models. Mol Nutr Food Res 55:1759-1770
34. Kaneko T, Wada H, Wakita Y, Minamikawa K, Nakase T, Mori Y, Deguchi K, Shirakawa S (1994) Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul Fibrinolysis 5:385-392
35. Allison BA, Nilsson L, Karpe F, Hamsten A, Eriksson P (1999) Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells. Arterioscler Thromb Vasc Biol 19:1354-1360
36. Liu L, Zhao SP, Wen T, Zhou HN, Hu M, Li JX (2008) Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients. Coron Artery Dis 19:145-151
37. Montegaard C, Tulk HM, Lauritzen L, Tholstrup T, Robinson LE (2010) Acute ingestion of long-chain (n-3) polyunsaturated fatty acids decreases fibrinolysis in men with metabolic syndrome. J Nutr 140:38-43
38. Bourgeois CS, Wiggins D, Hems R, Gibbons GF (1995) VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am J Physiol 269:E208-E215
39. Gibbons GF (1986) Hyperlipidaemia of diabetes. Clin Sci (Lond) 71:477-486
40. Eriksson P, Nilsson L, Karpe F, Hamsten A (1998) Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol 18:20-26